Tectonic Therapeutic, Inc.

General ticker "TECX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $411.2M (TTM average)

Tectonic Therapeutic, Inc. does not follow the US Stock Market performance with the rate: -0.0%.

Estimated limits based on current volatility of 3.2%: low 19.29$, high 20.57$

Factors to consider:

  • Total employees count: 49 as of 2018
  • Current price 15.0% below estimated low
  • Earnings for 9 months up through Q3 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [22.90$, 60.03$]
  • 2025-12-31 to 2026-12-31 estimated range: [14.95$, 40.59$]

Financial Metrics affecting the TECX estimates:

  • Negative: with PPE of -6.2 at the end of fiscal year the price was very high
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -8.49 <= 0.33
  • Negative: negative Industry operating cash flow (median)
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: Shareholder equity ratio, % of 92.07 > 63.39

Similar symbols

Short-term TECX quotes

Long-term TECX plot with estimates

Financial data

YTD 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.00MM
Operating Expenses $44.65MM $58.02MM
Operating Income $-44.65MM $-58.02MM
Non-Operating Income $1.82MM $0.03MM
Interest Expense $0.15MM $0.11MM
R&D Expense $36.97MM $41.36MM
Income(Loss) $-42.82MM $-57.98MM
Profit(Loss)* $-42.82MM $-57.98MM
Stockholders Equity $-84.64MM $140.78MM
Assets $39.40MM $152.91MM
Operating Cash Flow $-40.68MM $-59.08MM
Capital expenditure $0.28MM $0.16MM
Investing Cash Flow $-0.28MM $-0.16MM
Financing Cash Flow $33.75MM $171.71MM
Earnings Per Share** $-11.59 $-3.93

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.